Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 262 publications
Hematopoietic Cell Transplantation for Blastic Plasmacytoid Dendritic Cell Neoplasm: Clinical Practice Guidelines From the American Society for Transplantation and Cellular Therapy.
Journal: Transplantation and cellular therapy
Published: August 10, 2026
Reduced-Dose Post-Transplant Cyclophosphamide (PTCy 40-40) in Allogeneic Hematopoietic Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: May 26, 2026
Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22.
Journal: Blood cancer discovery
Published: May 18, 2026
Outcomes of Tocilizumab for Cytokine Release Syndrome after Post-Transplant Cyclophosphamide.
Journal: Transplantation and cellular therapy
Published: April 22, 2026
Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22.
Journal: Research square
Published: February 23, 2026
Outcomes of people living with acute lymphoblastic leukemia who received inotuzumab ozogamicin before a stem cell transplant: a plain language summary.
Journal: Future oncology (London, England)
Published: December 08, 2025
Cutaneous adverse events following CAR T-cell therapy in hematologic malignancies.
Journal: Blood cancer journal
Published: November 01, 2025
Challenges and considerations in developing trispecific CAR-Ts for B-cell malignancies.
Journal: Expert opinion on biological therapy
Published: October 28, 2025
Last Updated: 09/26/2026